TEMITOPE O AJANI

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family TAMPA, FL NPI 1215644752

General Payments — all program years on this page

$540.37

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 24
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $524.54 across 23 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $524.5423

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $15.831
2024 $524.5423

Records — PY2024 (23)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100260279 Novo Nordisk Inc $20.32 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100380411 Novo Nordisk Inc $17.86 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100605120 Novo Nordisk Inc $24.35 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104220427 AstraZeneca Pharmaceuticals LP $15.52 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105413423 AstraZeneca Pharmaceuticals LP $16.44 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105734993 AstraZeneca Pharmaceuticals LP $114.75 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116313747 GlaxoSmithKline, LLC. $26.52 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117186124 Amgen Inc. $20.56 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117186126 Amgen Inc. $20.99 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117186128 Amgen Inc. $21.42 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117490868 Amgen Inc. $13.75 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117490870 Amgen Inc. $16.97 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117490872 Amgen Inc. $14.84 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130960448 PFIZER INC. $20.41 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131978453 PFIZER INC. $14.63 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132294996 SCPHARMACEUTICALS INC. $15.58 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135923384 Lilly USA, LLC $14.38 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135978898 Lilly USA, LLC $24.26 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135979032 Lilly USA, LLC $19.05 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139464510 Astellas Pharma US Inc $22.58 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141760197 Merck Sharp & Dohme LLC $14.39 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150135443 SHIELD THERAPEUTICS INC $15.95 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150156648 SHIELD THERAPEUTICS INC $19.02 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.